Angiographic Restenosis in Ephesos Coronary Stents: Experience From a Large Medical Center in Ankara,Turkey

Abstract

Coronary stent restenosis, which emerges in late periods after implantation, has not been completely abolished. Our aim was to investigate the restenosis rates of Ephesos coronary stents. In all, 96 patients (66 men) with 135 Ephesos coronary stents were included. Control angiograms were performed after 160 ± 60 days. Quantitative coronary analysis was performed during the procedure and control angiogram. The stents were divided into 2 groups according to the presence or absence of restenosis. Groups were compared with clinical and angiographic variables. Restenosis was observed in 31 (23%) of 135 stents. Preprocedure percent diameter stenosis was higher (P = .02), whereas minimum lumen diameter ( P = .02), mean age (P < .001), and hypertension incidence ( P = .043) was less, and there was a trend toward smaller stent size ( P = .054) in the restenosis group. By multivariate analysis, age <50 years (P < .001) and stent size <3.0 mm (P = .016) were independent predictors of restenosis. Ephesos coronary stents seems to have acceptable restenosis rates.

Keywords

Ephesos coronary stent restenosis

Get full access to this article

View all access options for this article.

References

Baim DS , Cutlip DE , Midei M. , et al. Final results of a randomized trial comparing the multi-link stent with the Palmaz-Schatz stent for narrowings in native coronary arteries . Am J Cardiol. 2001;87:157-162.

Kandzari DE , Tcheng JE , Zidar JP Coronary artery stents: evaluating new designs for contemporary percutaneous intervention. Catheter Cardiovasc Interv. 2002;56:562-576.

Holmes DR In-stent restenosis. Rev Cardiovasc Med. 2001;2:115-119.

Schwartz RS , Henry TD Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med. 2002;3(suppl 5):4S-9S.

Serruys PW , de Jaegere P. , Kiemeneij F. , et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.

Fischman DL , Leon MB , Baim DS , et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.

McClean DR , Eigler NL Stent design: implications for restenosis. Rev Cardiovasc Med. 2002;3(suppl 5):16S-22S.

Smith SC Jr , Dove JT , Jacobs AK , et al. ACC/AHA Guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215-2239.

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406-1432.

10.

Ellis SG , Vandormael MG , Cowley MJ , et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis group. Circulation. 1990;82:1193-1202.

11.

Moliterno DJ , Topol EJ Restenosis: epidemiology and treatment. In: Topol EJ , ed. Textbook of Cardiovascular Medicine. Philadelphia, PA: Lippincott Williams & Wilkins ; 2002:1715-1750.

12.

Sayın T. , Berkalp B. , Akyürek Ö. , Kervancıoğlu C. , Oral D. Angiographic and clinical follow-up after coronary implantation of the ACS Multilink Duet Stent: a single center experience. Jpn Heart J. 2001 ;42:409-416.

13.

Kastrati A. , Dirschinger J. , Boekstegers P. , et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomazed comparison of five stent types in 1147 unselected patients. Catheter Cardiovasc Interv . 2000;50:290-297.

14.

Grech ED ABC of interventional cardiology. Percutaneous coronary intervention . II: the procedure. BMJ. 2003; 326:1137-1140.

15.

Amant C. , Bauters C. , Bodart J. , et al. D allele of the angiotensin-I converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation . 1997; 96:56-60.

16.

Gürlek A. , Gülec S. , Karabulut H. , et al. Relation between the insertion/deletion polymorphism of the angiotensin-I converting enzyme gene and restenosis after coronary stenting . J Cardiovasc Risk. 2000;7:403-407.